CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-09-28
DOI
10.3389/fimmu.2018.02235
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epratuzumab for the treatment of systemic lupus erythematosus
- (2018) Daniel Geh et al. Expert Review of Clinical Immunology
- CD22 Promotes B-1b Cell Responses to T Cell–Independent Type 2 Antigens
- (2018) Karen M. Haas et al. JOURNAL OF IMMUNOLOGY
- Decreased CD22 expression and intracellular signaling aberrations in B cells of patients with systemic sclerosis
- (2018) Konstantinos Melissaropoulos et al. RHEUMATOLOGY INTERNATIONAL
- Efficacy of Epratuzumab, an Anti-CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome
- (2018) Jacques-Eric Gottenberg et al. Arthritis & Rheumatology
- CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice
- (2018) Naoko Matsubara et al. Frontiers in Immunology
- Human CD22 Inhibits Murine B Cell Receptor Activation in a Human CD22 Transgenic Mouse Model
- (2017) Kyle J. Bednar et al. JOURNAL OF IMMUNOLOGY
- CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
- (2017) Terry J Fry et al. NATURE MEDICINE
- Molecular basis of human CD22 function and therapeutic targeting
- (2017) June Ereño-Orbea et al. Nature Communications
- Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials
- (2017) Megan E. B. Clowse et al. Arthritis & Rheumatology
- CD22 is required for formation of memory B cell precursors within germinal centers
- (2017) Craig P. Chappell et al. PLoS One
- CD72 negatively regulates B lymphocyte responses to the lupus-related endogenous toll-like receptor 7 ligand Sm/RNP
- (2016) Chizuru Akatsu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Besides an ITIM/SHP-1-dependent pathway, CD22 collaborates with Grb2 and plasma membrane calcium-ATPase in an ITIM/SHP-1-independent pathway of attenuation of Ca2+i signal in B cells
- (2016) Jie Chen et al. Oncotarget
- Engagement of CD22 on B cells with the monoclonal antibody epratuzumab stimulates the phosphorylation of upstream inhibitory signals of the B cell receptor
- (2016) Simon Lumb et al. Journal of Cell Communication and Signaling
- The mechanistic impact of CD22 engagement with epratuzumab on B cell function: Implications for the treatment of systemic lupus erythematosus
- (2015) Thomas Dörner et al. AUTOIMMUNITY REVIEWS
- Nanoscale organization and dynamics of the siglec CD22 cooperate with the cytoskeleton in restraining BCR signalling
- (2015) F. Gasparrini et al. EMBO JOURNAL
- Unmasking of CD22 Co-receptor on Germinal Center B-cells Occurs by Alternative Mechanisms in Mouse and Man
- (2015) Matthew S. Macauley et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An extracatalytic function of CD45 in B cells is mediated by CD22
- (2015) Sarah Coughlin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Autoregulatory function of interleukin-10-producing pre-naïve B cells is defective in systemic lupus erythematosus
- (2015) Ji Hyun Sim et al. ARTHRITIS RESEARCH & THERAPY
- Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-α, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients
- (2015) Vanessa Fleischer et al. ARTHRITIS RESEARCH & THERAPY
- Beyond apoptosis in lupus
- (2014) Lucrezia Colonna et al. CURRENT OPINION IN RHEUMATOLOGY
- TLR-mediated STAT3 and ERK activation controls IL-10 secretion by human B cells
- (2014) Bi-Sheng Liu et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Associations of genetic polymorphisms of Siglecs with human diseases
- (2014) Takashi Angata GLYCOBIOLOGY
- Dendritic Cell-Dependent Inhibition of B Cell Proliferation Requires CD22
- (2014) L. Santos et al. JOURNAL OF IMMUNOLOGY
- CD22 Regulates Time Course of Both B Cell Division and Antibody Response
- (2014) T. Onodera et al. JOURNAL OF IMMUNOLOGY
- Siglec-G Deficiency Leads to More Severe Collagen-Induced Arthritis and Earlier Onset of Lupus-like Symptoms in MRL/lpr Mice
- (2014) S. Bokers et al. JOURNAL OF IMMUNOLOGY
- Transcriptional programs of lymphoid tissue capillary and high endothelium reveal control mechanisms for lymphocyte homing
- (2014) Mike Lee et al. NATURE IMMUNOLOGY
- The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease
- (2014) Jennifer Müller et al. Nature Reviews Rheumatology
- Shp1 signalling is required to establish the long-lived bone marrow plasma cell pool
- (2014) Yan-Feng Li et al. Nature Communications
- Targeting CD22 in B-cell Malignancies: Current Status and Clinical Outlook
- (2013) Loretta Sullivan-Chang et al. BIODRUGS
- Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis
- (2013) Matthew S. Macauley et al. JOURNAL OF CLINICAL INVESTIGATION
- STALing B cell responses with CD22
- (2013) Craig P. Chappell et al. JOURNAL OF CLINICAL INVESTIGATION
- Overexpression of TLR7 promotes cell-intrinsic expansion and autoantibody production by transitional T1 B cells
- (2013) Natalia V. Giltiay et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cd72c Is a Modifier Gene that Regulates Faslpr-Induced Autoimmune Disease
- (2013) M. Xu et al. JOURNAL OF IMMUNOLOGY
- CD22 Is Required for Protection against West Nile Virus Infection
- (2013) D. Y. Ma et al. JOURNAL OF VIROLOGY
- Epratuzumab for Systemic Lupus Erythematosus
- (2013) DJ Wallace et al. LUPUS
- M89V Sialic Acid Acetyl Esterase (SIAE) and All Other Non-Synonymous Common Variants of This Gene Are Catalytically Normal
- (2013) Vasant Chellappa et al. PLoS One
- Siglecs as sensors of self in innate and adaptive immune responses
- (2012) James C. Paulson et al. Annals of the New York Academy of Sciences
- Extrafollicular B cell activation by marginal zone dendritic cells drives T cell–dependent antibody responses
- (2012) Craig P. Chappell et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Bone Marrow Dendritic Cell-Mediated Regulation of TLR and B Cell Receptor Signaling in B Cells
- (2012) V. J. Sindhava et al. JOURNAL OF IMMUNOLOGY
- B Cell Receptor Signal Transduction in the GC Is Short-Circuited by High Phosphatase Activity
- (2012) A. M. Khalil et al. SCIENCE
- B-cell selection and the development of autoantibodies
- (2012) Natalia V Giltiay et al. ARTHRITIS RESEARCH & THERAPY
- Regulation of B Cell Functions by the Sialic Acid-Binding Receptors Siglec-G and CD22
- (2012) Julia Jellusova et al. Frontiers in Immunology
- Targeting B lymphoma with nanoparticles bearing glycan ligands of CD22
- (2011) Weihsu C. Chen et al. LEUKEMIA & LYMPHOMA
- Toll-like receptor driven B cell activation in the induction of systemic autoimmunity
- (2011) Nathaniel M. Green et al. SEMINARS IN IMMUNOLOGY
- IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes
- (2010) J.-F. Seite et al. BLOOD
- Decrease of sialic acid residues as an eat-me signal on the surface of apoptotic lymphocytes
- (2010) H. M. Meesmann et al. JOURNAL OF CELL SCIENCE
- Immune Complex-Mediated Enhancement of Secondary Antibody Responses
- (2010) C. L. Goins et al. JOURNAL OF IMMUNOLOGY
- CD22 x Siglec-G Double-Deficient Mice Have Massively Increased B1 Cell Numbers and Develop Systemic Autoimmunity
- (2010) J. Jellusova et al. JOURNAL OF IMMUNOLOGY
- CD22 Is a Recycling Receptor That Can Shuttle Cargo between the Cell Surface and Endosomal Compartments of B Cells
- (2010) M. K. O'Reilly et al. JOURNAL OF IMMUNOLOGY
- CD22 Regulates Adaptive and Innate Immune Responses of B Cells
- (2010) Norihito Kawasaki et al. Journal of Innate Immunity
- Functionally defective germline variants of sialic acid acetylesterase in autoimmunity
- (2010) Ira Surolia et al. NATURE
- Autoantibody-mediated regulation of B cell responses by functional anti-CD22 autoantibodies in patients with systemic sclerosis
- (2009) M. Odaka et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- CD22 expression on blastic plasmacytoid dendritic cell neoplasms and reactivity of anti-CD22 antibodies to peripheral blood dendritic cells
- (2009) Edmunds Z. Reineks et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo
- (2009) Bao Hoa Duong et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Generation of Influenza-Specific Humoral Responses Is Impaired in ST6Gal I-Deficient Mice
- (2009) J. Zeng et al. JOURNAL OF IMMUNOLOGY
- REFINEMENT OF THE CLINICAL PHENOTYPE IN MUSK-RELATED CONGENITAL MYASTHENIC SYNDROMES
- (2009) V. Mihaylova et al. NEUROLOGY
- CD24-Siglec G/10 discriminates danger- from pathogen-associated molecular patterns
- (2009) Yang Liu et al. TRENDS IN IMMUNOLOGY
- Esterases and autoimmunity: the sialic acid acetylesterase pathway and the regulation of peripheral B cell tolerance
- (2009) Shiv Pillai et al. TRENDS IN IMMUNOLOGY
- Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: Delineation by expression of CD27, IgD, and CD95
- (2008) Annett M. Jacobi et al. ARTHRITIS AND RHEUMATISM
- B-cell tolerance checkpoints in health and autoimmunity
- (2008) Eric Meffre et al. CURRENT OPINION IN IMMUNOLOGY
- Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes
- (2008) P. Fiorina et al. DIABETES
- CD22: an inhibitory enigma
- (2008) Jennifer A. Walker et al. IMMUNOLOGY
- B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase
- (2008) Annaiah Cariappa et al. JOURNAL OF EXPERIMENTAL MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now